3.00 USD
↗ 0.17 (6.01%)AT CLOSE (03:59 PM EDT)
Insight Molecular Diagnostics Inc. Common Stock
IMDXNASDAQ • USD
3.00
↘ 0.00 (0.13%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
3.00
↘ 0.00 (0.13%)
Market: CLOSED
Insight Molecular Diagnostics Inc. Common Stock (IMDX) is currently trading at $3.02. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (231.7%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 26, 2026.
Open?$2.89
High?$3.03
Low?$2.77
Prev. Close?$2.83
Volume?160.0K
Avg. Volume?300.9K
VWAP?$2.92
Rel. Volume?0.53x
Bid / Ask
Bid?$2.45 × 5.0K
Ask?$3.50 × 500
Spread?$1.05
Midpoint?$2.98
Valuation & Ratios
Market Cap?98.2M
Shares Out?32.7M
Float?25.8M
Float %?78.9%
P/E Ratio?N/A
P/B Ratio?-4.61
EPS?-$1.51
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.
Employees
58
Market Cap
92.6M
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Website
Listed
2015-12-30
Address
2 INTERNATIONAL PLAZA DR., SUITE 510
NASHVILLE, TN 37217
Phone: 949-409-7600
NASHVILLE, TN 37217
Phone: 949-409-7600
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?69
Piotroski F-Score?0/9Weak
Altman Z-Score?-24.53Distress
Confidence?44%Low
Short InterestModerate
Short % of Float?3.68%Low
Short Interest?949.5K
Days to Cover?3.3
Free Float25.8M
Avg Daily Volume292.4K
Settlement Date2026-10-15
Financial Health
Current Ratio?2.00Strong
Quick Ratio?1.98Adequate
Cash Ratio?1.73Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-4.61CHEAP▾
S&P97
P/S?58.79HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-2.1CHEAP▾
S&P97
EV/Sales?48.15HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?231.7%STRONG▾
Peers50
S&P97
ROA?-167.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-30875000
Enterprise Value?$80.4M
Fundamentals ratios updated end of day